Home/Filings/4/0001384101-23-000004
4//SEC Filing

Anderson Bonnie H 4

Accession 0001384101-23-000004

CIK 0001384101other

Filed

Jan 17, 7:00 PM ET

Accepted

Jan 18, 5:08 PM ET

Size

11.0 KB

Accession

0001384101-23-000004

Insider Transaction Report

Form 4
Period: 2023-01-17
Anderson Bonnie H
DirectorPresident & CEO
Transactions
  • Sale

    Common Stock

    2023-01-17$26.30/sh29,506$776,11167,455 total
  • Sale

    Common Stock

    2023-01-17$26.64/sh4,494$119,72662,961 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2023-01-1734,000102,117 total
    Exercise: $5.61Exp: 2026-03-14Common Stock (34,000 underlying)
  • Exercise/Conversion

    Common Stock

    2023-01-17$5.61/sh+34,000$190,74096,961 total
Holdings
  • Common Stock

    (indirect: By Trust)
    123,514
Footnotes (4)
  • [F1]The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 25, 2022.
  • [F2]Represents weighted average sales price. Sale prices for the transactions range from $25.58 to $26.58. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
  • [F3]Represents weighted average sales price. Sale prices for the transactions range from $26.59 to $26.70. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
  • [F4]The option is fully vested.

Issuer

VERACYTE, INC.

CIK 0001384101

Entity typeother

Related Parties

1
  • filerCIK 0001588970

Filing Metadata

Form type
4
Filed
Jan 17, 7:00 PM ET
Accepted
Jan 18, 5:08 PM ET
Size
11.0 KB